125 related articles for article (PubMed ID: 3068260)
1. Epoprostenol (PGI2, prostacyclin) during high-risk hemodialysis: preventing further bleeding complications.
Swartz RD; Flamenbaum W; Dubrow A; Hall JC; Crow JW; Cato A
J Clin Pharmacol; 1988 Sep; 28(9):818-25. PubMed ID: 3068260
[TBL] [Abstract][Full Text] [Related]
2. Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent.
Zusman RM; Rubin RH; Cato AE; Cocchetto DM; Crow JW; Tolkoff-Rubin N
N Engl J Med; 1981 Apr; 304(16):934-9. PubMed ID: 7010166
[TBL] [Abstract][Full Text] [Related]
3. Controlled study of heparin versus epoprostenol sodium (prostacyclin) as the sole anticoagulant for chronic hemodialysis.
Caruana RJ; Smith MC; Clyne D; Crow JW; Zinn JM; Diehl JH
Blood Purif; 1991; 9(5-6):296-304. PubMed ID: 1819317
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin substitution for heparin in long-term hemodialysis.
Smith MC; Danviriyasup K; Crow JW; Cato AE; Park GD; Hassid A; Dunn MJ
Am J Med; 1982 Nov; 73(5):669-78. PubMed ID: 6753575
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of epoprostenol (PGI2) versus heparin (H) in hemodialysis (HD).
Dubrow A; Flamenbaum W; Mittman N; Hall J; Zinn J
Trans Am Soc Artif Intern Organs; 1984; 30():52-4. PubMed ID: 6398552
[No Abstract] [Full Text] [Related]
6. Prostacyclin (epoprostenol) as the sole antithrombotic agent in postdilutional hemofiltration.
Canaud B; Mion C; Arujo A; N'Guyen QV; Paleyrac G; Hemmendinger S; Cazenave JP
Nephron; 1988; 48(3):206-12. PubMed ID: 2965311
[TBL] [Abstract][Full Text] [Related]
7. Prevention of coagulation during hemodialysis by a combination of the stable prostacyclin analogue CG 4203 and low-dose heparin.
Maurin N; Ballmann M
Clin Nephrol; 1988 Jul; 30(1):35-41. PubMed ID: 3061692
[TBL] [Abstract][Full Text] [Related]
8. Haemodialysis with prostacyclin (Epoprostenol) alone.
Rylance PB; Gordge MP; Ireland H; Lane DA; Weston MJ
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():281-6. PubMed ID: 3887374
[TBL] [Abstract][Full Text] [Related]
9. Prostacyclin versus citrate in continuous haemodiafiltration: an observational study in patients with high risk of bleeding.
Balik M; Waldauf P; Plásil P; Pachl J
Blood Purif; 2005; 23(4):325-9. PubMed ID: 16118487
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the effectiveness of hemodialysis using only heparin or prostacyclin with heparin].
Kuźniewski M; Sułowicz W
Przegl Lek; 1990; 47(3):328-31. PubMed ID: 2236625
[TBL] [Abstract][Full Text] [Related]
11. Prostacyclin and thromboxane in chronic uremia: effect of hemodialysis.
Ylikorkala O; Huttunen K; Järvi J; Viinikka L
Clin Nephrol; 1982 Aug; 18(2):83-7. PubMed ID: 6754193
[TBL] [Abstract][Full Text] [Related]
12. Preventing hemorrhage in high-risk hemodialysis: regional versus low-dose heparin.
Swartz RD; Port FK
Kidney Int; 1979 Oct; 16(4):513-8. PubMed ID: 548596
[TBL] [Abstract][Full Text] [Related]
13. The in vitro bleeding time while using a stable prostacyclin analogue during hemodialysis.
Maurin N
Int J Artif Organs; 1988 Jul; 11(4):243-8. PubMed ID: 3045018
[TBL] [Abstract][Full Text] [Related]
14. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
[TBL] [Abstract][Full Text] [Related]
15. Prostacyclin safer than heparin in haemodialysis.
Arze RS; Ward MK
Lancet; 1981 Jul; 2(8236):50. PubMed ID: 6113427
[No Abstract] [Full Text] [Related]
16. Prostacyclin and heparin during haemodialysis: comparative effects.
Camici M; Evangelisti L
Life Support Syst; 1986; 4(3):205-9. PubMed ID: 3537544
[TBL] [Abstract][Full Text] [Related]
17. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
[TBL] [Abstract][Full Text] [Related]
18. Minimizing hemorrhagic complications in dialysis patients.
Lohr JW; Schwab SJ
J Am Soc Nephrol; 1991 Nov; 2(5):961-75. PubMed ID: 1760540
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure.
Davenport A; Will EJ; Davison AM
Nephron; 1994; 66(4):431-7. PubMed ID: 8015647
[TBL] [Abstract][Full Text] [Related]
20. Hemodialysis using heparin-bound Hemophan in patients at risk of bleeding.
Lee KB; Kim B; Lee YH; Yoon SJ; Kang WH; Huh W; Kim DJ; Oh HY; Kim YG
Nephron Clin Pract; 2004; 97(1):c5-10. PubMed ID: 15153761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
